Best Options Strategy for LEGN
Looking for the best options strategy for Legend Biotech Corporation (LEGN)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live LEGN option chain right now, and a simple map from your view on LEGN to the strategy that fits it. Model any of them in the calculator before you trade.
About LEGN
Legend Biotech Corporation (LEGN) is a major company in Biotechnology. Options traders on LEGN tend to watch , since these can drive large moves in the share price.
About Legend Biotech Corporation
Legend Biotech discovers and develops cell therapies focused primarily on cancer treatment. The company's lead product, cilta-cel, is a CAR-T therapy designed to treat multiple myeloma by engineering a patient's own immune cells to recognize and attack cancer cells. Beyond this advanced candidate, Legend maintains a pipeline of earlier-stage CAR-T therapies targeting various cancers including leukemias and solid tumors like gastric, pancreatic, and lung cancers. The company is also exploring next-generation approaches with allogeneic gamma delta CAR-T and CAR-NK cell therapies, which don't require patient-specific customization and are currently in early trials in China.
Legend generates revenue through partnerships with major pharmaceutical companies. Janssen Biotech collaborates on cilta-cel's development and commercialization, while Novartis holds a license for Legend's CAR-T platform targeting delta-like ligand protein 3. The company operates across three primary geographic markets: the United States, China, and Europe. Founded in 2014 and based in Somerset, New Jersey, Legend operates as a publicly traded biopharmaceutical firm dependent on advancing its clinical programs…
Today's top-scoring strategy for LEGN
Our engine ranks defined-risk strategies on the live LEGN chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.
| Action | Qty | Type | Strike | Premium |
|---|---|---|---|---|
| Buy | 1× | PUT | $20 | $0.15 |
| Sell | 1× | PUT | $30 | $1.52 |
| Sell | 1× | CALL | $30 | $1.60 |
| Buy | 1× | CALL | $40 | $0.12 |
Simulation
Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.
Live scan from 2026-07-02 · quotes delayed ~15 minutes
Implied volatility
LEGN is currently trading with high implied volatility, which makes its options expensive — and attractive to sell. On the options we scanned that was around 66% implied volatility, and higher implied volatility means richer premiums and wider expected moves.
Options on LEGN currently price in about 66% implied volatility, versus roughly 129% the stock has actually realised over the past month. That makes options relatively cheap — an edge for strategies that buy premium, such as long calls, long puts and debit spreads.
Off that volatility, the options market is pricing a move of about ±$3.91 (±13%) in LEGN by 2026-07-17 — a range of roughly $26 to $33.82. Strikes inside that band hold most of the premium and see most of the action.
Across strikes, puts and calls on LEGN carry a fairly symmetric implied volatility — no strong directional fear is priced in either way.
Liquidity and tradeability
LEGN options are thinly traded, with wide bid-ask spreads around 24.3% near the money that eat into any edge — favour simple single-leg or tight defined-risk trades, and always use limit orders.
Earnings & IV crush
LEGN's next earnings report is due around August 10, 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.
Key figures
- Market cap
- $5.8B
- Beta (vs market)
- 0.35
- 52-week range
- $16.24–$45.30 (47% up the range)
- Short interest
- 17.7% of float · 4.8 days to cover
With 17.7% of LEGN's float sold short, squeeze and gap risk are elevated — one reason its options can stay expensive.
Other strong setups for LEGN
If your view on LEGN differs, these also scored well in the latest scan:
How to choose an options strategy for LEGN
Start with your outlook on LEGN, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:
Bullish
Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.
Long Call → Bull Call Spread →Bearish
Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.
Long Put → Bear Put Spread →Neutral
Sell an iron condor to collect premium while LEGN stays between two strikes, or write a covered call against shares you already own.
Iron Condor → Covered Call →How we pick the best strategy
For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →
Open LEGN in the free calculator →
Frequently asked questions
What is the best options strategy for LEGN?
It depends on your outlook. Bullish traders often use a long call or bull call spread on LEGN; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.
Are LEGN options liquid enough to trade?
Legend Biotech Corporation (LEGN) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.
How much money do I need to trade LEGN options?
Buying a single LEGN call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.
Is this financial advice?
No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade LEGN or any security. Do your own research.
What does Legend Biotech Corporation do?
Legend Biotech Corporation (LEGN) operates in the Biotechnology industry. The "About Legend Biotech Corporation" section above gives a fuller picture of what the company does and how it earns money.
Does Legend Biotech Corporation pay a dividend?
Legend Biotech Corporation does not currently pay a dividend, so there is no ex-dividend assignment risk to plan around for options strategies.
When does Legend Biotech Corporation next report earnings?
Legend Biotech Corporation's next earnings are expected around August 10, 2026. Implied volatility usually climbs into the report and drops sharply afterwards (IV crush) — important for any options position held over the date.
Tickers related to LEGN
Comparing LEGN with similar names can help you choose the best options strategy:
Company information
- Headquarters
- 2101 Cottontail Lane, Somerset, NJ, 08873, United States
- Industry
- Biotechnology
- Employees
- 3,100
- CEO
- Dr. Ying Huang Ph.D.
- Phone
- 737 317 5050
- Website
- legendbiotech.com
Best Options Strategy by Ticker →
Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.